UniProt ID | NIF3L_HUMAN | |
---|---|---|
UniProt AC | Q9GZT8 | |
Protein Name | NIF3-like protein 1 {ECO:0000305|PubMed:11124544} | |
Gene Name | NIF3L1 {ECO:0000312|HGNC:HGNC:13390} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 377 | |
Subcellular Localization | Cytoplasm . Nucleus . Interaction with COPS2 may regulate localization to the nucleus. | |
Protein Description | May function as a transcriptional corepressor through its interaction with COPS2, negatively regulating the expression of genes involved in neuronal differentiation.. | |
Protein Sequence | MLSSCVRPVPTTVRFVDSLICNSSRSFMDLKALLSSLNDFASLSFAESWDNVGLLVEPSPPHTVNTLFLTNDLTEEVMEEVLQKKADLILSYHPPIFRPMKRITWNTWKERLVIRALENRVGIYSPHTAYDAAPQGVNNWLAKGLGACTSRPIHPSKAPNYPTEGNHRVEFNVNYTQDLDKVMSAVKGIDGVSVTSFSARTGNEEQTRINLNCTQKALMQVVDFLSRNKQLYQKTEILSLEKPLLLHTGMGRLCTLDESVSLATMIDRIKRHLKLSHIRLALGVGRTLESQVKVVALCAGSGSSVLQGVEADLYLTGEMSHHDTLDAASQGINVILCEHSNTERGFLSDLRDMLDSHLENKINIILSETDRDPLQVV | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
82 (in isoform 2) | Ubiquitination | - | 7.55 | 21890473 | |
101 | Acetylation | PPIFRPMKRITWNTW CCCCCCCCCCCCCCH | 43.24 | 25953088 | |
104 | Phosphorylation | FRPMKRITWNTWKER CCCCCCCCCCCHHHH | 19.39 | 24719451 | |
109 | Acetylation | RITWNTWKERLVIRA CCCCCCHHHHHHHHH | 30.80 | 19608861 | |
109 | Ubiquitination | RITWNTWKERLVIRA CCCCCCHHHHHHHHH | 30.80 | 21890473 | |
109 (in isoform 1) | Ubiquitination | - | 30.80 | 21890473 | |
109 | Ubiquitination | RITWNTWKERLVIRA CCCCCCHHHHHHHHH | 30.80 | 21890473 | |
124 | Phosphorylation | LENRVGIYSPHTAYD HHHCCCCCCCCCHHH | 15.38 | - | |
125 | Phosphorylation | ENRVGIYSPHTAYDA HHCCCCCCCCCHHHC | 14.32 | - | |
130 | Phosphorylation | IYSPHTAYDAAPQGV CCCCCCHHHCCCCCH | 13.79 | 25839225 | |
143 | Ubiquitination | GVNNWLAKGLGACTS CHHHHHHHCCCCCCC | 53.12 | - | |
157 | Ubiquitination | SRPIHPSKAPNYPTE CCCCCCCCCCCCCCC | 72.77 | - | |
161 | Phosphorylation | HPSKAPNYPTEGNHR CCCCCCCCCCCCCCC | 15.52 | 26437602 | |
181 | Ubiquitination | NYTQDLDKVMSAVKG ECCCCHHHHHHHHCC | 47.32 | - | |
181 | Acetylation | NYTQDLDKVMSAVKG ECCCCHHHHHHHHCC | 47.32 | 25038526 | |
187 | Ubiquitination | DKVMSAVKGIDGVSV HHHHHHHCCCCCEEE | 50.28 | - | |
207 (in isoform 2) | Ubiquitination | - | 36.47 | 21890473 | |
215 (in isoform 2) | Ubiquitination | - | 31.09 | 21890473 | |
216 | Ubiquitination | INLNCTQKALMQVVD EECCCHHHHHHHHHH | 25.90 | - | |
219 | Sulfoxidation | NCTQKALMQVVDFLS CCHHHHHHHHHHHHH | 3.21 | 30846556 | |
226 | Phosphorylation | MQVVDFLSRNKQLYQ HHHHHHHHHCHHHHH | 33.53 | 21712546 | |
229 | Ubiquitination | VDFLSRNKQLYQKTE HHHHHHCHHHHHHHC | 40.34 | - | |
234 (in isoform 1) | Ubiquitination | - | 34.27 | 21890473 | |
234 | Ubiquitination | RNKQLYQKTEILSLE HCHHHHHHHCEECCC | 34.27 | 21890473 | |
234 | Ubiquitination | RNKQLYQKTEILSLE HCHHHHHHHCEECCC | 34.27 | 21890473 | |
242 | Ubiquitination | TEILSLEKPLLLHTG HCEECCCCCEEHHCC | 46.38 | 21890473 | |
242 (in isoform 1) | Ubiquitination | - | 46.38 | 21890473 | |
242 | Acetylation | TEILSLEKPLLLHTG HCEECCCCCEEHHCC | 46.38 | 25038526 | |
242 | 2-Hydroxyisobutyrylation | TEILSLEKPLLLHTG HCEECCCCCEEHHCC | 46.38 | - | |
255 | Phosphorylation | TGMGRLCTLDESVSL CCCCCCCCCCHHHHH | 41.66 | 23403867 | |
259 | Phosphorylation | RLCTLDESVSLATMI CCCCCCHHHHHHHHH | 19.37 | - | |
261 | Phosphorylation | CTLDESVSLATMIDR CCCCHHHHHHHHHHH | 22.90 | 19664994 | |
264 | Phosphorylation | DESVSLATMIDRIKR CHHHHHHHHHHHHHH | 21.69 | 23403867 | |
276 | Phosphorylation | IKRHLKLSHIRLALG HHHHHCHHHHHHHHH | 18.45 | 20068231 | |
348 | Phosphorylation | NTERGFLSDLRDMLD CCCCCHHHHHHHHHH | 32.13 | 24719451 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of NIF3L_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of NIF3L_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NIF3L_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-109, AND MASS SPECTROMETRY. |